ArticleJournal of hepatocellular carcinoma2025

Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study.

Xuehan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.